• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » North Shore-LIJ Health System joins Cleveland Clinic’s Innovation Alliance

North Shore-LIJ Health System joins Cleveland Clinic’s Innovation Alliance

February 28, 2012
CenterWatch Staff

North Shore-LIJ Health System, the second-largest nonprofit in the U.S. secular healthcare system, has joined Cleveland Clinic’s Innovation Alliance program to enhance the discovery, development, deployment and commercialization of new technologies.

The primary goal of the collaboration is to leverage the capabilities of Cleveland Clinic to help turn the discoveries made at North Shore-LIJ’s Feinstein Institute for Medical Research facility into diagnostic and treatment options that can be used to improve patient care. The alliance, which will also identify other opportunities for joint projects within North Shore-LIJ, will be led by Cleveland Clinic chief innovations officer Thomas Graham, M.D., and executive director Chris Coburn, and Feinstein Institute president Kevin Tracey, M.D.

Cleveland Clinic will provide extensive support to the Feinstein Institute to help bring medical technologies from the "bench to the bedside." The two institutions will have a shared focus on developing new and innovative technologies that are commercially viable, while always exploring additional collaborative opportunities that exist between the two organizations.

Over the past decade, breakthroughs originating at the Feinstein Institute have led to the creation of 11 start-up companies and more than 200 active patents that comprise 80 distinct technologies. Through this collaboration with Cleveland Clinic, Feinstein Institute officials say they hope to pursue commercialization ventures focused on diseases such as rheumatoid arthritis, lupus, cancer, sepsis, Alzheimer's and schizophrenia.

North Shore-LIJ is the second institution in the country to join Cleveland Clinic's Innovation Alliance program, the first being MedStar Health—the mid-Atlantic's largest healthcare system.

    Upcoming Events

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing